Nucleoprotein is ADP-ribosylated

Stable Identifier
R-HSA-9729279
Type
Reaction [transition]
Species
Homo sapiens
Related Species
Severe acute respiratory syndrome coronavirus 2
Compartment
cytosol
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Nucleoprotein is ADP-ribosylated
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
This COVID-19 event has been created by a combination of computational inference (see https://reactome.org/documentation/inferred-events) from SARS-CoV-1 data and manual curation, as described in the summation for the overall SARS-CoV-2 infection pathway.

Nucleoprotein (N) is ADP-ribosylated. The modification is maintained both in the cell and in virions (Grunewald et al, 2018). Members of the protein mono-ADP-ribosyltransferase (PARP) enzyme family are thought to catalyze this reaction (Fehr et al. 2020)
Literature References
PubMed ID Title Journal Year
32029454 The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions

Aikawa, M, Fehr, AR, Higashi, H, Kerr, CM, Mukai, S, Singh, SA

Genes Dev. 2020
29199039 The coronavirus nucleocapsid protein is ADP-ribosylated

Perlman, S, Grunewald, ME, Fehr, AR, Athmer, J

Virology 2018
Participants
Input
Output
Participates
as an event of
Catalyst Activity

NAD+ ADP-ribosyltransferase activity of PARPs [cytosol]

Physical Entity
PARPs [cytosol] (Homo sapiens)
Activity
NAD+ ADP-ribosyltransferase activity (GO:0003950)
Inferred From
Nucleoprotein is ADP-ribosylated (Homo sapiens)
Disease
Name Identifier Synonyms
COVID-19 DOID:0080600 2019 Novel Coronavirus (2019-nCoV), Wuhan seafood market pneumonia virus infection, 2019-nCoV infection, Wuhan coronavirus infection
Authored
Stephan, R  (2020-08-28)
Reviewed
Acencio, ML  (2021-05-09)
Acencio, ML  (2020-09-09)
Created
Stephan, R  (2021-04-28)
Cite Us!